Century Therapeutics Faces Termination of BMS Agreement

TipRanksDec 13 17:27 ET

Bristol-Myers Squibb Notified Century Therapeutics On Dec 12 To Terminate Collaboration Agreement, Effective March 12, 2025; Co To Evaluate Opportunities In AML And Multiple Myeloma In The Context Of The Ongoing Strategic Review Of Century's...

BenzingaDec 13 17:07 ET

Express News | Century Therapeutics - to Evaluate Opportunities in Aml and Multiple Myeloma

ReutersDec 13 17:03 ET

Express News | Century Therapeutics - Termination Effective March 12, 2025

ReutersDec 13 17:03 ET

Express News | Century Therapeutics- Bms Notified Co on Dec 12 to Terminate Collaboration Agreement With Century Therapeutics

ReutersDec 13 17:03 ET

Analysts Are Bullish on Top Healthcare Stocks: Keros Therapeutics (KROS), Century Therapeutics (IPSC)

TipRanksDec 5 11:52 ET · Ratings